# A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations

> **NCT06135168** · PHASE1 · COMPLETED · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Pediatric Growth Hormone Deficiency (PGHD)

## Interventions

- **DRUG:** PEG-rhGH with new preparation
- **DRUG:** PEG-rhGH with present preparation

## Key facts

- **NCT ID:** NCT06135168
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-31
- **Primary completion:** 2023-11-29
- **Final completion:** 2024-03-18
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06135168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06135168, "A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06135168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*